Outpatient antimicrobial therapy for infective endocarditis is safe

Dylan Rajaratnam, Rohan Rajaratnam

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

Infective endocarditis (IE) is common and is associated with significant mortality, morbidity and health care burden. Outpatient antimicrobial therapy in carefully selected patients, supported by a multidisciplinary team is safe and beneficial for both the patient and the health care system. In this article, we review current literature of outpatient antimicrobial therapy in infective endocarditis and propose that most patients with IE should be considered and appropriate pathways developed to facilitate this.
Original languageEnglish
Pages (from-to)207-215
Number of pages9
JournalHeart , Lung and Circulation
Volume30
Issue number2
DOIs
Publication statusPublished - 2021

Fingerprint

Dive into the research topics of 'Outpatient antimicrobial therapy for infective endocarditis is safe'. Together they form a unique fingerprint.

Cite this